We are live on
!
Find out more
BAMCO Inc Portfolio holdings
AUM
$66.6B
Turnover
22.96%
1-Year Est. Return
7.35%
This Fund
S&P 500
This Quarter
Est. Return
+9.43%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$38.7B
AUM Growth
+$987M
(+2.6%)
Cap. Flow
-$875M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
44.33%
Holding
344
New
16
Increased
94
Reduced
151
Closed
28
Avg Time Held
5.4
years
Top 10 Avg Time Held
8
years
Top 20 Avg Time Held
6.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$74.2M |
| 2 |
ServiceTitan Inc
TTAN
|
+$71.4M |
| 3 |
Kilroy Realty
KRC
|
+$58.6M |
| 4 |
Macerich
MAC
|
+$58.2M |
| 5 |
Equinix
EQIX
|
+$45.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$113M |
| 2 |
Vertiv
VRT
|
+$95M |
| 3 |
Rexford Industrial Realty
REXR
|
+$76.8M |
| 4 |
Altair Engineering Inc
ALTR
|
+$74.3M |
| 5 |
Ansys
ANSS
|
+$65.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.88% |
| 2 | Financials | 21.45% |
| 3 | Technology | 20.59% |
| 4 | Real Estate | 8.45% |
| 5 | Healthcare | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Zoetis
ZTS
$32.4B
| $2.04M | 0.01% |
12,500
-4,500
| -26% | -$805K |
2019 Q4
20 quarters
|
|
277
Tenet Healthcare
THC
$22.2B
| $1.96M | 0.01% |
15,500
-9,500
| -38% | -$1.41M |
2024 Q2
2 quarters
|
|
278
HCA Healthcare
HCA
$101B
| $1.95M | 0.01% |
6,500
-11,800
| -64% | -$4.12M |
2022 Q4
8 quarters
|
|
279
Manchester United
MANU
$3.55B
| $1.93M | 0.01% |
111,479
| – | – |
2013 Q2
46 quarters
|
|
280
T. Rowe Price
TROW
$21.6B
| $1.73M | ﹤0.01% |
15,260
| – | – |
2013 Q2
46 quarters
|
|
281
Ultragenyx Pharmaceutical
RARE
$1.5B
| $1.68M | ﹤0.01% |
40,000
-8,000
| -17% | -$397K |
2024 Q3
1 quarter
|
|
282
Biohaven
BHVN
$1.73B
| $1.64M | ﹤0.01% |
44,000
-1,000
| -2% | -$46.7K |
2024 Q2
2 quarters
|
|
283
Edgewise Therapeutics
EWTX
$4.15B
| $1.6M | ﹤0.01% |
+60,000
| New | +$1.91M |
2024 Q4
0 quarters
|
|
284
Weyerhaeuser
WY
$14B
| $1.54M | ﹤0.01% |
+54,548
| New | +$1.7M |
2024 Q4
0 quarters
|
|
285
Blackrock
BLK
$174B
| $1.23M | ﹤0.01% |
1,200
| – | – |
2018 Q1
27 quarters
|
|
286
Victory Capital Holdings
VCTR
$6.72B
| $1.09M | ﹤0.01% |
16,596
| – | – |
2022 Q4
8 quarters
|
|
287
Jack Henry & Associates
JKHY
$11B
| $1.05M | ﹤0.01% |
6,000
| – | – |
2020 Q1
19 quarters
|
|
288
Wave Life Sciences
WVE
$629M
| $1.05M | ﹤0.01% |
+85,000
| New | +$1.13M |
2024 Q4
0 quarters
|
|
289
CarMax
KMX
$7.47B
| $1.03M | ﹤0.01% |
12,582
-1,516
| -11% | -$119K |
2013 Q2
46 quarters
|
|
290
Essent Group
ESNT
$5.73B
| $1.02M | ﹤0.01% |
18,653
| – | – |
2016 Q3
33 quarters
|
|
291
Kymera Therapeutics
KYMR
$8.99B
| $1.01M | ﹤0.01% |
25,000
| – | – |
2024 Q3
1 quarter
|
|
292
Alexander's
ALX
$1.2B
| $1M | ﹤0.01% |
5,000
| – | – |
2013 Q2
46 quarters
|
|
293
Rocket Pharmaceuticals
RCKT
$259M
| $943K | ﹤0.01% |
75,000
-809,341
| -92% | -$12.2M |
2022 Q3
9 quarters
|
|
294
Rivian
RIVN
$18.9B
| $856K | ﹤0.01% |
64,389
-162,157
| -72% | -$1.87M |
2021 Q4
12 quarters
|
|
295
Home Depot
HD
$308B
| $778K | ﹤0.01% |
2,000
| – | – |
2013 Q4
44 quarters
|
|
296
Equifax
EFX
$18.9B
| $765K | ﹤0.01% |
3,000
+100
| +3% | +$26.8K |
2022 Q1
11 quarters
|
|
297
Berkshire Hathaway Class A
BRK.A
$1.13T
| $681K | ﹤0.01% |
1
| – | – |
2016 Q3
33 quarters
|
|
298
Littelfuse
LFUS
$9.95B
| $668K | ﹤0.01% |
2,836
+519
| +22% | +$129K |
2016 Q1
35 quarters
|
|
299
Genmab
GMAB
$23.3B
| $661K | ﹤0.01% |
31,691
-40,683
| -56% | -$894K |
2020 Q4
16 quarters
|
|
300
Lam Research
LRCX
$347B
| $651K | ﹤0.01% |
9,019
+709
| +9% | +$53.8K |
2022 Q1
11 quarters
|
|
Similar funds
BAMCO Inc's Q4 2024 Portfolio in Review
As of Q4 2024, BAMCO Inc held 344 positions worth $38.7B, up 2.6% from $37.7B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
BAMCO Inc's Q4 2024 filing shows 16 new, 94 increased, 151 reduced and 28 closed positions. Its largest new stake was Expedia Group: 430,454 shares worth $80.2M. The largest sale was Tesla, an estimated $113M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 26% a quarter earlier, followed by Financials and Technology.
- BAMCO Inc's largest Q4 2024 buy was Expedia Group: 430,454 shares worth $80.2M.
- BAMCO Inc added most to Macerich in Q4 2024, an estimated $58.2M increase.
- BAMCO Inc's biggest Q4 2024 reduction was Tesla, cutting an estimated $113M.
- BAMCO Inc fully exited Rexford Industrial Realty in Q4 2024, selling an estimated $76.8M.
- BAMCO Inc's ten largest holdings make up 44% of its $38.7B portfolio in Q4 2024.
- BAMCO Inc opened 16 new positions and closed 28 in Q4 2024.
- BAMCO Inc's portfolio value rose 2.6% quarter-over-quarter to $38.7B.
Based on BAMCO Inc's 13F filing for Q4 2024, filed 14 Feb 2025.